"In addition, Glaxo is developing an intravenous form of Relenza for the sickest patients."
Not so according to GSK web site - see my previous post Rotahaler Study - follow link - go up one level and you will see that IV program Id No NAI108166 has been closed.
- Forums
- ASX - By Stock
- BTA
- lani, iv relenza,flumist breaking news reuters
lani, iv relenza,flumist breaking news reuters, page-4
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)